Market Research Assistance

On the Web
Refine Result

By Date

Last Month
Last 3 Months
Last 6 Months
Last Year
Last 2 Years

By Price

< $1000
$1000-$2500
$2501-$4000
$4001-$5500
$5501-$7500
$7501-$9000
>$9000
Hepatitis Drugs

    Hepatitis Drugs Market Research Reports

    Titlepublishedprice

    Market Research Report on Global and Chinese Boceprevir Industry, 2009-2019

    By Prof Research
    "......he report then explores global and China's top manufacturers of Boceprevir listing their product specification, capacity, Production value, and market share etc.; The report further analyzes quantitatively 2009-2014 global and China's total market of......"
    20-Apr-2014$2400

    Market Research Report on Global and Chinese Entecavir Industry, 2009-2019

    By Prof Research
    "......report then explores global and China's top manufacturers of Entecavir listing their product specification, capacity, Production value, and market share etc.; The report further analyzes quantitatively 2009-2014 global and China's total market of Ent......"
    20-Apr-2014$2400

    Market Research Report on Global and Chinese Adefovir Industry, 2009-2019

    By Prof Research
    "......ort then explores global and China's top manufacturers of Adefovir listing their product specification, capacity, Production value, and market share etc.; The report further analyzes quantitatively 2009-2014 global and China's total market of Adefovi......"
    20-Apr-2014$2400

    Hepatitis Drugs Markets in China

    By AMID
    "......cture, marketing channels and major industry participants. Historical data (2003, 2008 and 2013) and long-term forecasts through 2018 and 2023 are presented. Major producers in China are profiled......."
    16-Apr-2014$4000

    Hepatitis C – Pipeline Review, H1 2014

    By Global Markets Direct
    "......rative analysis at various stages, therapeutics assessment by drug target, mechanism of action (MoA), route of administration (RoA) and molecule type, along with latest updates, and featured news and press releases. It also reviews key players involv......"
    28-Feb-2014$2500

    Hepatitis C Therapeutics in Major Developed Markets to 2019 – Outstanding Recent Approvals and Late-Stage Pipeline to Transform Clinical and Commercial Landscape

    By GBI Research
    "......on, ribavirin and, in patients infected with genotype 1 hepatitis C, one of two direct-acting antiviral agents (DAAs). Products with these mechanisms of action have performed strongly in the commercial setting, with the market leader Incivek (a DAA) ......"
    31-Jan-2014$3500

    Fendrix (Prophylactic Hepatitis B Virus Vaccines) – Forecast and Market Analysis to 2022

    By GlobalData
    "...... liver diseases. While the arrival of recombinant HBsAg vaccines has greatly reduced disease burden over the past two decades, questions surrounding vaccine uptake and effectiveness in adults, particularly in niche patient populations, still remain. ......"
    31-Jan-2014$3495

    PharmaPoint: Prophylactic Hepatitis B Virus Vaccines – Global Drug Forecast and Market Analysis to 2022

    By GlobalData
    "...... liver diseases. While the arrival of recombinant HBsAg vaccines has greatly reduced disease burden over the past two decades, questions surrounding vaccine uptake and effectiveness in adults, particularly in niche patient populations, still remain. ......"
    31-Jan-2014$9995

    Heplisav (Prophylactic Hepatitis B Virus Vaccines) – Forecast and Market Analysis to 2022

    By GlobalData
    "...... liver diseases. While the arrival of recombinant HBsAg vaccines has greatly reduced disease burden over the past two decades, questions surrounding vaccine uptake and effectiveness in adults, particularly in niche patient populations, still remain. ......"
    31-Jan-2014$3495

    PharmaPoint: Prophylactic Hepatitis B Virus Vaccines – US Drug Forecast and Market Analysis to 2022

    By GlobalData
    "...... liver diseases. While the arrival of recombinant HBsAg vaccines has greatly reduced disease burden over the past two decades, questions surrounding vaccine uptake and effectiveness in adults, particularly in niche patient populations, still remain. ......"
    31-Jan-2014$4995
    Live Chat
    Live Chat by Comm100